Q2Wow... didn't bother posting, the results spoke for themselves.
My model had their revenues and net income contracting steadily. To see the results so different was somewhat shocking. I have to revalue the stock to try to better understand it's nature.
Their product revenues keep on growing instead of shrinking, while licensing has been shrinking (though not in Q2, because of smart moves by management) as it should. The product revenues may be indicative of just how strong their Canadian presence is (and valuable).
Very interesting... what is the "value" of their Canadian distribution system if it is superior to what is normal.
Still sitting on my big pile of shares.
This stock is not only undervalued (I think it's easily worth > 3.50 normally, on the LOW end), it might also deserve a premium to what I thought it was worth due to things mentioned above, which I have to try to find a way to get a feel for, value wise.
The current management might be vastly superior, and able to exploit the small size and nimbleness of CPH.
Well, all those random thoughts flit about left and right -)
Meanwhile sitting long and strong, diamond hands at the moment, GLTA!